Prior to founding Integrated Insights, David was a Director at Eidetics, where he managed a wide variety of consulting and market research engagements. Before his six years at Eidetics, David worked as a market researcher and decision modeler at Amgen. Prior to that he worked in the Health Care Consulting group at PriceWaterhouseCoopers. He has a bachelor’s degree in biology from Cornell University and an MBA from New York University.

David has over twelve years experience in the pharmaceutical and medical device industry with in-depth knowledge of both the scientific and commercial sides of the business. Because David began his career in the lab of a start-up biotechnology firm, he is well versed in scientific issues and frequently uses this background for technically complex categories and classes. David’s therapeutic areas of expertise include immunology, oncology, osteoporosis, pulmonology, hematology, infectious disease, vaccines, neurology, nephrology, endocrinology, gastroenterology, ophthalmology, pain management, and women’s health.

David has a deep base of business analysis skills including a wide spectrum of qualitative and quantitative market research techniques, group moderation capabilities, decision framing tools, and experience in strategic forecasting.

John joins Integrated Insights from The Parthenon Group, a management consulting firm located in Boston, MA. As a principal at Parthenon, John worked on strategic engagements ranging from sales force optimization, to new market entry tactics, to long-term horizontal and vertical opportunity assessment.

Prior to Parthenon, John worked for five years as a Manager and Analyst in Eidetics’ Decision Modeling Group, focusing on quantitative research. In this role, John supported and led a variety of multivariate modeling efforts in the areas of new product opportunity assessment, product positioning and message optimization (both pre- and post-launch), strategic market segmentation, and pricing. John has experience in a range of disease categories including anti-infectives, oncology, gastrointestinal disorders, hormone replacement therapy, depression and bipolar disorder, multiple sclerosis, and Parkinson’s disease, as well as medical devices. John has conducted research with physicians, patients, caretakers, nurses, hospital administrators, and managed care organizations.

John holds a bachelor’s degree in economics from Williams College and MBA with a specialization in finance from the MIT Sloan School of Management.

Krishna is a quantitative psychologist with a Ph.D. from the Ohio State University, and 15 years of experience in quantitative modeling. His experience in pharmaceutical market research spans a wide variety of therapeutic categories and includes experience in the hypogonadism market, having led the analysis for market landscape and demand studies for products in this market. He has led many successful segmentation studies in a variety of therapeutic categories.

Prior to working in the field of pharmaceutical market research, Krishna was the lead statistical coordinator for the College Board’s Advanced Placement Program at Educational Testing Service in Princeton, NJ. He also served as a visiting faculty member at The Ohio State University.

Krishna has a particular interest in segmentation, and will presented an “Application of Data-Based Components Analysis in Attitudinal Segmentation” at a conference to be held at The Ohio State University in September 2010.

Phil is an independent consultant specializing in the application of decision analysis, real options valuation, portfolio optimization, and risk analysis to strategic business problems.

For over 20 years, Phil has helped companies develop corporate and asset strategies and improve portfolio management and business operations. For the past seven years, Phil was a Director at Baxter BioScience where he used his expertise in the development and implementation of portfolio optimization to help guide the allocation of R&D investments.

Prior to his time at Baxter, Phil founded the Decision Science function at Amgen, where he initiated new decision-making processes with team leaders and executives and led strategy projects in development assets, marketing initiatives, pricing decisions, licensing activities, and regulatory strategies. Prior to that, Phil was a leader at Applied Decision Analysis, a consulting firm and pioneer in applying decision theory to corporate and public policy problems.

Phil received degrees from both Westmont College in mathematics and Stanford University in engineering and management science.

Andrea joins Integrated Insights as an analyst working on a variety of projects.

Prior to joining Integrated Insights, Andrea worked as a Behavioral Health Researcher and Technical Writer at HealthForumOnline, writing and updating online continuing education courses for allied healthcare professionals. Prior to that, she was a Research and Program Coordinator for the Penn Program for Mindfulness at the University of Pennsylvania.

Andrea has also served as a Community Health Advisor for Peace Corps Zambia (2003-2006) and Liberia (2010).

Andrea holds a Masters in Health Psychology from the University of the Sciences in Philadelphia and a Bachelors in Psychology from Virginia Tech.

Kim joins Integrated Insights from Avalere Health, a health policy advisory services company in Washington DC. As a director at Avalere, Kim helped establish and run a new product development function at the firm, including identifying new product ideas, conducting market research with customers to evaluate opportunity, developing use cases, pro forma forecasts, and business cases, selecting vendors for development, and leading internal team and vendors throughout development to product launch.  

Prior to Avalere Health, Kim worked for five years as a manager and analyst at Eidetics, focused on both qualitative and quantitative research. Kim led a variety of client accounts as a moderator interviewing patients, providers, and payers, and managed projects with methodologies including landscape assessment, segmentation, conjoint models, message optimization, and forecasting.  Kim has experience in a variety of therapeutic areas including women’s health, oncology, nephrology, gastrointestinal disorders, and multiple sclerosis.

Kim holds a bachelor’s degree in Business Communications from Cornell University.

Theresa is a skilled and accomplished marketing research professional and moderator with 25 years of experience providing strategic insights to support marketing decisions for health care products. She has broad experience in custom marketing research specializing in qualitative and quantitative research among patients, physicians, pharmacists and payers. She has experience in both US and international healthcare markets. Her work has had an emphasis on new product and concept evaluations as well market sizing, product positioning, message development, and segmentation.

Most recently Theresa was the principal of Dunn Research and Consulting, where she provided qualitative marketing research services to the pharmaceutical industries. Prior to that she served for over ten years as a Senior Director at Eidetics / Quintiles and before that as a Vice President at Migliara/Kaplan Associates.

Theresa's areas of therapeutic experience include: cardiology, oncology, women's health, osteoporosis, respiratory, dermatologic and CNS conditions.

Theresa has BS in Bacteriology from the University of Arkansas and an MBA from Ohio State University.

Gregory joins Integrated Insights from Deloitte Consulting, where he spent two years as a Manager and a Senior Consultant in the Strategy practice. At Deloitte, Gregory worked with a number of companies across the healthcare industry on topics such as commercial strategy development, market and competitive assessments, growth strategy, market entry, knowledge management, acquisition screening, and customer value.

Before Deloitte, Gregory worked for four years at Eidetics, a Boston based market research firm, within their Decision Modeling Group. As a Manager and Analyst with Eidetics, Gregory primarily developed multivariate quantitative models based on primary research to help clients with difficult questions related to new product forecasting, prescriber or patient segmentation, pricing models, and message optimization. Gregory has worked across a number of therapeutic categories, including migraines, diabetes, bipolar disorder, schizophrenia, and women's health.

Gregory holds an MBA from New York University as well as a BS in Operations Research and Industrial Engineering from Cornell University.